Sponsor:
Weill Medical College of Cornell University
Code:
NCT07073209
Conditions
Hip Fractures
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PENG Block Administration
Femoral Block Administration
Bupivacaine , epinephrine Dexamethasone
Brief summary:
Conditions
Hip Fractures
Study ID
NCT07073209
Start date
Jul 10, 2025
Status verified date
May, 2026
Completion date
Apr, 2027
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
352 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: PENG Block Administration
experimental: Femoral Block Administration
Interventions
PENG Block Administration
Femoral Block Administration
Bupivacaine , epinephrine Dexamethasone
Primary outcome measure
Central contacts
Locations
Weill Cornell Medicine
Recruiting
Manhattan, New York, United States, 10065
Contacts
Sponsor
Weill Medical College of Cornell University
Last update posted
May 15, 2026
Last verified
May, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-05-15.